These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25060161)

  • 1. Calculation of volatile anaesthetics consumption from agent concentration and fresh gas flow.
    Biro P
    Acta Anaesthesiol Scand; 2014 Sep; 58(8):968-72. PubMed ID: 25060161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of calculated volatile agent consumption from fresh gas content.
    Biro P; Kneschke O; Theusinger OM
    Acta Anaesthesiol Scand; 2015 May; 59(5):619-24. PubMed ID: 25882167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring the costs of inhaled anaesthetics.
    Lockwood GG; White DC
    Br J Anaesth; 2001 Oct; 87(4):559-63. PubMed ID: 11878724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoeconomics of volatile inhalational anaesthetic agents: an 11-year retrospective analysis.
    Weinberg L; Story D; Nam J; McNicol L
    Anaesth Intensive Care; 2010 Sep; 38(5):849-54. PubMed ID: 20865868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic and Environmental Considerations During Low Fresh Gas Flow Volatile Agent Administration After Change to a Nonreactive Carbon Dioxide Absorbent.
    Epstein RH; Dexter F; Maguire DP; Agarwalla NK; Gratch DM
    Anesth Analg; 2016 Apr; 122(4):996-1006. PubMed ID: 26735317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global warming potential of inhaled anesthetics: application to clinical use.
    Ryan SM; Nielsen CJ
    Anesth Analg; 2010 Jul; 111(1):92-8. PubMed ID: 20519425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Economic aspects of modern inhalation anesthetics with sevoflurane as an example].
    Bach A; Böhrer H; Schmidt H; Motsch J; Martin E
    Anaesthesist; 1997 Jan; 46(1):21-8. PubMed ID: 9082863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Costs of sevoflurane in the perioperative setting].
    Bach A
    Anaesthesist; 1998 Nov; 47 Suppl 1():S87-96. PubMed ID: 9893887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halothane, isoflurane and sevoflurane in pediatric anesthesia: can we decrease costs without increasing adverse events?
    Nava-Ocampo AA; Alarcón-Almanza JM; Moyao-García D; Ramírez-Mora JC; Salmerón J
    Paediatr Anaesth; 2004 Oct; 14(10):891-2. PubMed ID: 15385025
    [No Abstract]   [Full Text] [Related]  

  • 10. Reliability of the volatile agent consumption display in the Draeger Primus™ anesthesia machine.
    Biro P; Kneschke O; Theusinger OM
    J Clin Monit Comput; 2015 Oct; 29(5):601-4. PubMed ID: 25388511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of fresh gas flow on the amount of sevoflurane vaporized during 1 minimum alveolar concentration anaesthesia for day surgery: a clinical study.
    Ekbom K; Assareh H; Anderson RE; Jakobsson JG
    Acta Anaesthesiol Scand; 2007 Mar; 51(3):290-3. PubMed ID: 17250746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financial and environmental costs of manual versus automated control of end-tidal gas concentrations.
    Tay S; Weinberg L; Peyton P; Story D; Briedis J
    Anaesth Intensive Care; 2013 Jan; 41(1):95-101. PubMed ID: 23362897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viscosity and density of common anaesthetic gases: implications for flow measurements.
    Habre W; Asztalos T; Sly PD; Petak F
    Br J Anaesth; 2001 Oct; 87(4):602-7. PubMed ID: 11878731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhalation anesthesiology and volatile liquid anesthetics: focus on isoflurane, desflurane, and sevoflurane.
    Sakai EM; Connolly LA; Klauck JA
    Pharmacotherapy; 2005 Dec; 25(12):1773-88. PubMed ID: 16305297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nitrous oxide free low-flow anesthesia].
    Baum J; Sievert B; Stanke HG; Brauer K; Sachs G
    Anaesthesiol Reanim; 2000; 25(3):60-7. PubMed ID: 10920482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of bispectral index to minimum alveolar concentration during isoflurane, sevoflurane or desflurane anaesthesia.
    Kim JK; Kim DK; Lee MJ
    J Int Med Res; 2014 Feb; 42(1):130-7. PubMed ID: 24366495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Which settings to optimize anaesthetics delivery: fresh gas flow or delivered fraction?].
    Quénet E; Weil G; Billard V
    Ann Fr Anesth Reanim; 2008 Nov; 27(11):900-8. PubMed ID: 18990536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of isoflurane, halothane, and sevoflurane vaporizers during high oxygen flow and at maximum vaporizer dial setting.
    Ambrisko TD; Klide AM
    Am J Vet Res; 2011 Jun; 72(6):751-6. PubMed ID: 21627520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A second-generation blood substitute (perflubron emulsion) increases the blood solubility of modern volatile anesthetics in vitro.
    Cuignet OY; Baele PM; Van Obbergh LJ
    Anesth Analg; 2002 Aug; 95(2):368-72, table of contents. PubMed ID: 12145053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fresh gas flow is not the only determinant of volatile agent consumption: a multi-centre study of low-flow anaesthesia.
    Coetzee JF; Stewart LJ
    Br J Anaesth; 2002 Jan; 88(1):46-55. PubMed ID: 11881883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.